Enjoy Cultural Experiences During Maui Derm Hawaii 2024
Cultural experiences abound at Grand Wailea during Maui Derm Hawaii 2024!
Read MoreJan 15, 2024
Cultural experiences abound at Grand Wailea during Maui Derm Hawaii 2024!
Read MoreJan 8, 2024
Patients reporting increased fatigue have a higher hazard of death compared with those who did not after adjusting for covariates.
Read MoreJan 7, 2024
The 2024 Winter Clinical Dermatology Conference offers an array of sessions spotlighting psoriasis, so plan your schedule accordingly!
Read MoreJan 6, 2024
The 2024 Winter Clinical Dermatology Conference is offering live virtual broadcasts of conference sessions.
Read MoreJan 5, 2024
When you’re ready for a break from 2024 Winter Clinical Dermatology Conference sessions, Oahu is ready for you with a range of island activities.
Read MoreDec 22, 2023
Treatment that includes acalabrutinib can improve progression-free survival in treatment-naïve patients with chronic lymphocytic leukemia.
Read MoreDec 22, 2023
Dr. Reckamp co-authored a paper that addresses the need for cautious progression from phase 1 to phase 3 trials for advanced NSCLC, summarized here.
Read MoreDec 18, 2023
A sandwich treatment model that includes acalabrutinib and rituximab in combination with R-DHAOx chemotherapy shows encouraging results in phase 2 trial.
Read MoreDec 18, 2023
Patients with rare inherited retinal diseases often must undertake a diagnostic odyssey before receiving a correct diagnosis.
Read MoreDec 14, 2023
Do you remember the MS research presented at AAN? Test your knowledge now and see how you rank!
Read MoreDec 14, 2023
Do you remember the psoriasis research presented at Fall Clinical Dermatology Conference 2023? Test your knowledge now!
Read MoreDec 11, 2023
In age-related macular degeneration, depression can directly impact patient care through loss to follow-up, cancellations, and lack of treatment adherence.
Read MoreDec 9, 2023
At 2023 NACLC, Heather Law, MA, presented a recap of “Associations of HRQOL with daily functioning/communication with care teams in patients with ALK+ NSCLC.”
Read MoreDec 6, 2023
Decision support tools help patients with MS more effectively engage with their providers and adhere to their treatment.
Read MoreDec 6, 2023
Do you remember the eNSCLC research presented at ESMO? Test your knowledge now!
Read MoreDec 5, 2023
The following is a summary of “Benefit of Allogeneic Transplant in 1st Complete Remission in...
Read MoreDec 5, 2023
The following is a summary of “Autologous Transplant (auto-HCT) Is Associated with Improved...
Read MoreDec 5, 2023
The following is a summary of “Addition of Acalabrutinib to Lenalidomide and Rituximab...
Read MoreDec 4, 2023
April Armstrong, MD, MPH, spoke with Physician’s Weekly about the role of interleukin inhibitors, IL-17 and IL-23, in treating psoriasis.
Read MoreDec 4, 2023
With over 275 exhibitors, the 65th ASH Annual Meeting exhibit hall is not to be missed!
Read More